NCT03399747View on ClinicalTrials.gov

Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients With Completely Excised LocalizedGastrointestinal CD(Cluster of Differentiation Antigen)20(+) Diffuse Large B-cell Lymphoma

PHASE2UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 7, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG

Abb-R-CHOP

"Completely Excised LocalizedGastrointestinal CD20 (+) Diffuse Large B-cell Lymphoma~3 Cycles(1 Cycle:4weeks) of Rituximab Plus CHOP (Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy"